Sinnovial is a biotechnology company created in September 2015 in partnership with Grenoble Alpes CHU and University of Sciences. It is specialized in the development of innovative personalized medicine devices to improve the Chronic Inflammatory Rheumatism (CIR) management in rheumatology (especially rheumatoid arthritis and ankylosing spondylitis). Our technology is based on the analysis of patients’ proteomic profile and the calculation of treatment response probabilities.
The right treatment, to the right patient, at the right time!
CIR, ALL CONCERNED
EACH PERSON IS UNIQUE
A patient. A treatment.
Medical developments must serve to everyone.
The aim of SinnoTest® is to enable the physician to improve his patient management by maximizing successful biotherapy treatment from the initiation of the medical procedure.